Spire Wealth Management Pacira Bio Sciences, Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$51.49 - $81.64 $25,745 - $40,820	-500 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$60.03 - $76.49 $30,015 - $38,245	500 New	500 $38,000
Q4 2021 Jan 14, 2022	SELL	$47.97 - $62.21 $4,797 - $6,221	-100 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$54.64 - $61.3 $27,320 - $30,650	-500 Reduced 83.33%	100 $6,000
Q1 2021 May 21, 2021	BUY	$59.31 - $78.82 $35,586 - $47,291	600 New	600 $42,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.